Cambridge Investment Research Advisors’s iShares iBonds Dec 2024 Term Corporate ETF IBDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-169,306
Closed -$4.27M 3628
2024
Q3
$4.27M Sell
169,306
-598,783
-78% -$15M 0.01% 888
2024
Q2
$19.3M Sell
768,089
-28,389
-4% -$711K 0.07% 272
2024
Q1
$20M Buy
796,478
+49,932
+7% +$1.25M 0.08% 250
2023
Q4
$18.6M Buy
746,546
+598,785
+405% +$14.8M 0.08% 245
2023
Q3
$3.65M Buy
147,761
+27,094
+22% +$668K 0.02% 816
2023
Q2
$2.97M Buy
120,667
+2,673
+2% +$65.7K 0.01% 929
2023
Q1
$2.9M Buy
117,994
+29,448
+33% +$722K 0.01% 918
2022
Q4
$2.16M Buy
88,546
+52,241
+144% +$1.27M 0.01% 1034
2022
Q3
$884K Sell
36,305
-67,114
-65% -$1.66M 0.01% 1561
2022
Q2
$2.56M Buy
103,419
+15,003
+17% +$373K 0.01% 929
2022
Q1
$2.22M Sell
88,416
-20,903
-19% -$533K 0.01% 1079
2021
Q4
$2.83M Buy
109,319
+70,246
+180% +$1.83M 0.01% 951
2021
Q3
$1.03M Buy
39,073
+4,779
+14% +$126K 0.01% 1493
2021
Q2
$904K Buy
34,294
+3,782
+12% +$99.9K ﹤0.01% 1601
2021
Q1
$805K Sell
30,512
-2,681
-8% -$71K ﹤0.01% 1585
2020
Q4
$882K Buy
33,193
+4,461
+16% +$118K 0.01% 1389
2020
Q3
$760K Sell
28,732
-653
-2% -$17.3K 0.01% 1344
2020
Q2
$775K Sell
29,385
-3,926
-12% -$101K 0.01% 1285
2020
Q1
$823K Buy
33,311
+15,305
+85% +$389K 0.01% 1083
2019
Q4
$463K Buy
18,006
+1,797
+11% +$46.1K ﹤0.01% 1637
2019
Q3
$416K Buy
16,209
+6,164
+61% +$158K ﹤0.01% 1628
2019
Q2
$256K Buy
+10,045
New +$251K ﹤0.01% 1847

Other funds holding IBDP

Cambridge Investment Research Advisors's IBDP Position: Q4 2024 in Review

Cambridge Investment Research Advisors sold out of iShares iBonds Dec 2024 Term Corporate ETF (IBDP) in Q4 2024, closing a stake of 169,306 shares — an estimated $4.27M sold.

Cambridge Investment Research Advisors first reported a position in IBDP in Q2 2019 and held it in 22 quarters. The position peaked at $20M in Q1 2024. 2 funds tracked by Wall St. Rank hold IBDP as of Q4 2024.

  • Cambridge Investment Research Advisors reported no remaining iShares iBonds Dec 2024 Term Corporate ETF position as of Q4 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 169,306 iShares iBonds Dec 2024 Term Corporate ETF shares in Q4 2024, an estimated $4.27M.
  • Cambridge Investment Research Advisors first reported a position in iShares iBonds Dec 2024 Term Corporate ETF in Q2 2019 and held it in 22 quarters.
  • Cambridge Investment Research Advisors's iShares iBonds Dec 2024 Term Corporate ETF position peaked at $20M in Q1 2024.
  • 2 funds tracked by Wall St. Rank held iShares iBonds Dec 2024 Term Corporate ETF as of Q4 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.